NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial ReportiCD ResearchFebruary 2, 2012 42 Pages - SKU: ICDR6792453 |
| Synopsis ICD Research's NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, competitive benchmarking, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company. Summary ICD Research's NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about NEC Corporation. ICD Research's NEC Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Scope
NEC Corporation (NEC) is a provider of information technology (IT) products and services globally. The company provides internet, broadband network and enterprise products such as servers, projectors, storage devices, monitors, networking and electron devices, and software solutions such as middleware, ERP software, and embedded system design software. It offers tailored solutions in the areas of computer, networking and electron devices through its six business segments, IT Services Business, Platform Business, Carrier Network Business, Social Infrastructure Business, Personal Solutions Business and Others. The company's products are sold in North America, Latin America, Europe, and Asia Pacific markets. NEC is headquartered in Tokyo, Japan. |
Related Markets
Pharmaceuticals Company Reports
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2012
- Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
- Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics
- Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals
- Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

